Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of ProAlgaZyme Novel Algae Infusion on HDL Cholesterol and C-Reactive Protein in Individuals With Metabolic Syndrome

NCT00518960 is registered in ClinicalTrials.gov with Health Enhancement Products, Inc. as lead sponsor.

NCT NCT00518960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00518960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of ProAlgaZyme Novel Algae Infusion on HDL Cholesterol and C-Reactive Protein in Individuals With Metabolic Syndrome
Lead sponsor
Health Enhancement Products, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2007
Completion date
September 30, 2007
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia, metabolic syndrome